Nabla vs Oracle Health Clinical AI Agent
An Oracle Health site can run either of these, because Nabla is one of the few scribes with a named Oracle Health integration, which makes this a genuine choice rather than a default. The evidence gap is the story. Nabla holds the only positive randomized result in this category, a 9.5 percent reduction in time in note against control in a trial it did not run, and publishes its data lifecycle to the point of backup expiry. The Oracle agent publishes no accuracy figure, no model card and no bias statement, and its documentation footprint has grown into order drafting without a corresponding growth in disclosure. Choose the agent if native order writing inside the record is the capability you are buying and you accept an unpublished error profile. Choose Nabla if you want documented efficiency and a data position you can read before signing.
- The only ambient scribe with a positive randomized controlled trial result, reducing time in note by 9.5 percent against control across roughly 72,000 encounters and the only arm in that trial to meet its primary endpoint.
- The data lifecycle is published in full: audio not stored, no training on user data, a configurable 14 day retention sized around clinician review, and backups expiring seven days later so deletion reaches the backup layer rather than stopping at the application.
- It is portable. More than 15 record systems named including Epic, Oracle Health, athenahealth, NextGen, Greenway and Altera, so the documentation programme survives a record system change instead of ending with it.
- Order creation is the capability Nabla deliberately does not have. Prescriptions, laboratory tests, imaging studies and follow up appointments drafted from ambient listening and written back as structured orders, inside the record.
- Native depth beats integrated depth on latency, identity and workflow. There is no launch step, no separate login and no note transfer to manage.
- It is already inside the contract, the security review and the support relationship, which for a constrained Oracle Health IT function can be worth more than a better documented alternative.
Side by Side
| Axis | N Nabla |
O Oracle Health Clinical AI Agent |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
The trial cited is Lukac et al, NEJM AI, 26 November 2025, NCT06792890, conducted in outpatient care at a single academic health system, so it does not establish note quality or inpatient performance. Nabla's free tier is reported not to include a business associate agreement, so evaluate on the tier you would contract, and its published per month pricing was withdrawn during 2026 in favour of a sales motion.
Oracle publishes no accuracy figure for note or order generation, no confidence threshold for drafted orders and no product scoped security or business associate documentation. Neither product is separately priced in a way that allows a like for like comparison.